ha14-1 and pd 98059
ha14-1 has been researched along with pd 98059 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bruno, T; Cianciulli, A; Ciuffreda, L; Cognetti, F; Del Bufalo, D; Milella, M; Mottolese, M; Trisciuoglio, D; Zangemeister-Wittke, U; Zupi, G | 1 |
Other Studies
1 other study(ies) available for ha14-1 and pd 98059
| Article | Year |
|---|---|
Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cells.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; bcl-X Protein; Benzopyrans; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Enzyme Inhibitors; Flavonoids; Flow Cytometry; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Nitriles; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transfection; Trastuzumab; Up-Regulation | 2004 |